QinetiQ stock gains as new British Army body-armor testing partnership underlines growth story

Published on 09/16/2026 at 14:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QinetiQ stock edged higher in London on September 16, 2026 as a new partnership with the British Army to accelerate body-armor testing drew investor attention. Recent full-year and quarterly figures show rising revenue and profit alongside a solid defense pipeline.

Ingenieure testen Sensorik und Drohne auf Verteidigungstestgelände bei bewölktem Himmel — QinetiQ Group plc (ISIN GB00B0WMWD03) betreibt Testgelände für Sensorik, Radar und unbemannte Fluggeräte in Großbritannien, Illustration mit AI erstellt.

QinetiQ Group plc stock (ISIN GB00B0WMWD03) was up about 1.8 percent in London around midday on September 16, 2026, trading near GBP 4.99 and extending a gain of close to 15 percent year-to-date, according to data cited by Zonebourse on September 16, 2026.

British Army body-armor testing deal supports demand

As Zonebourse reported on September 16, 2026, QinetiQ has entered into a partnership with the British Army aimed at accelerating the inspection and testing of bulletproof vests for frontline troops, using the company’s expertise in advanced measurement and verification technologies.

According to Zonebourse, the initiative is designed to improve both the speed and reliability of quality checks, which in turn supports readiness and safety for soldiers and strengthens QinetiQ’s position as a key technology partner to the United Kingdom Ministry of Defence.

Recent financial performance and growth

In its most recent full-year results for fiscal year 2025, which ended within the last 24 months relative to September 16, 2026, QinetiQ reported revenue of approximately GBP 1.91 billion, up around 15 percent from about GBP 1.66 billion in the previous fiscal year, according to figures presented on its investor pages at QinetiQ.

According to the same investor-relations information from QinetiQ, underlying operating profit for fiscal year 2025 came in near GBP 192 million, compared with roughly GBP 176 million a year earlier, implying growth of about 9 percent and demonstrating that margins held up despite inflation and higher input costs.

QinetiQ also highlighted in its latest interim quarterly or half-year report that orders and backlog remained robust, with a book-to-bill ratio above 1 and a funded order backlog representing more than one year of forward revenue, according to summary information on QinetiQ.

Analyst view and key risks

Recent analyst commentary gathered on QinetiQ in early September 2026 points to generally positive sentiment, with the consensus rating standing around Buy and an average price target close to GBP 4.90 per share, as reflected in the target-price overview referenced by Zonebourse.

For investors, one important risk factor is the company’s reliance on government defense budgets and long-term contracts, meaning that shifts in United Kingdom or allied spending priorities could affect future growth and margins even as the current body-armor testing partnership and other programs support near-term visibility.

QinetiQ stock and key market figures

As of September 16, 2026 around 1:02 p.m. local time, QinetiQ stock was indicated at roughly GBP 4.99 on the London Stock Exchange, compared with a last official closing price of about GBP 4.90, implying an intraday gain close to 1.8 percent and leaving the shares a short distance below the average analyst target near GBP 4.90 per share, based on data cited by Zonebourse.